The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner